Physician profile
Howard Winfield
NPI 1750383303
$2,392.89
in general payments reported to CMS, 2019-2025
29 companies · $385 in 2025
The $385 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $635 · 2020: $554 · 2021: $275 · 2022: $144 · 2023: $204 · 2024: $197 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $785.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $389.42 | 2019-2021 | |
| Abbvie INC. | $256.79 | 2019-2025 | Botox |
| Intuitive Surgical, INC. | $256.24 | 2020 | |
| Coloplast Corp | $131.55 | 2019-2025 | |
| Boston Scientific Corporation | $114.55 | 2019-2023 | Spaceoar Vue System - 10ml |
| Blue Earth Diagnostics | $107.21 | 2019-2025 | Posluma |
| Allergan, INC. | $105.87 | 2019-2022 | |
| Antares Pharma, INC. | $81.25 | 2019-2020 | |
| Procept Biorobotics Corporation | $78.32 | 2024-2025 | Aquabeam System |
| Abc Home Medical Supply, INC. | $72.00 | 2025 | |
| Medtronic USA, INC. | $69.48 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $66.39 | 2019-2022 | |
| Pfizer INC. | $66.11 | 2019-2022 | |
| Laborie Medical Technologies Corp. | $62.62 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Convatec INC. | $56.77 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $56.39 | 2019-2025 | Erleada |
| Medtronic, INC. | $53.48 | 2023-2025 | Interstim |
| Photocure INC | $52.60 | 2019-2020 | |
| Olympus America INC. | $49.18 | 2025 | Itind System |
| Verity Pharmaceuticals INC. | $42.80 | 2023-2025 | Trelstar |
| Axonics, INC. | $42.75 | 2023-2024 | Axonics |
| Dendreon Pharmaceuticals LLC | $37.62 | 2019-2020 | |
| Conmed Corporation | $32.35 | 2019-2025 | Conmed Specimen Retrieval, Airseal, Visiclear |
| Urogen Pharma, INC. | $31.27 | 2021-2023 | Jelmyto |
| Progenics Pharmaceuticals, INC. | $22.16 | 2023 | Pylarify |
| Ambu INC. | $16.87 | 2025 | |
| Innovation Technologies INC | $15.10 | 2023 | Irrisept |
| E.R. Squibb & Sons, L.L.C. | $13.65 | 2022 | |
| Urovant Sciences INC | $12.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Winfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.